Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for gestational diabetes
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on gestational diabetes or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on gestational diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via firstname.lastname@example.org
BMI: Body Mass Index DM: Diabetes Mellitus GDM: GestationalDiabetes Mellitus gest: gestational age HbA1c: Glycated haemoglobin OGTT: Oral glucose tolerance test =: greater than or equal to : greater than Queensland Clinical Guideline: Gestationaldiabetes mellitus. Guideline No: MN15.33-V1-R20 Assess all women for risk factors GDM care GDM diagnosis OGTT (preferred test for diagnosis) One or more of: • Fasting = 5.1 mmol/L • 1 hour = 10 mmol/L • 2 hour = 8.5 mmol/L HbA1c (if OGTT not suitable (...) • Maternal age = 40 years • Family history DM (1 st degree relative or sister with GDM) • Previous macrosomia (birth weight > 4500 g or > 90 th percentile • Previous perinatal loss • Polycystic Ovarian Syndrome • Medications (corticosteroids, antipsychotics) • Multiple pregnancy Queensland Clinical Guideline: Gestationaldiabetes mellitus Refer to online version, destroy printed copies after use Page 4 of 38 Flowchart: Intrapartum management for GDM requiring Insulin and/or Metformin Metformin • Cease
A Randomized Controlled Trial to Evaluate the Effects of a Smartphone Application-Based Lifestyle Coaching Program on Gestational Weight Gain, Glycemic Control, Maternal, and Neonatal Outcomes in Women With GestationalDiabetes Mellitus: The SMART-GDM Stu A Randomized Controlled Trial to Evaluate the Effects of a Smartphone Application-Based Lifestyle Coaching Program on Gestational Weight Gain, Glycemic Control, Maternal, and Neonatal Outcomes in Women With GestationalDiabetes Mellitus (...) Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Diabetes Care Actions . 2020 Nov 12;dc201216. doi: 10.2337/dc20-1216. Online ahead of print. A Randomized Controlled Trial to Evaluate the Effects of a Smartphone Application-Based Lifestyle Coaching Program on Gestational Weight Gain, Glycemic Control, Maternal, and Neonatal Outcomes in Women With GestationalDiabetes
Use of metformin hydrochloride in gestationaldiabetes: a systematic review Use of metformin hydrochloride in gestationaldiabetes: a systematic review | Research, Society and Development Open Menu Search Search / / / Review Article Jéssica Costa de Oliveira Faculdade de Enfermagem Nova Esperança de Mossoró Luanne Eugênia Nunes Faculdade de Enfermagem Nova Esperança de Mossoró Franciso Ernesto de Souza Neto Faculdade de Enfermagem Nova Esperança de Mossoró Rosueti Diógenes de Oliveira-Filho (...) Faculdade de Enfermagem Nova Esperança de Mossoró DOI: Keywords: GestationalDiabetes; Metformin; Pregnant women; Systematic review. Abstract GestationalDiabetes Mellitus is a condition characterized by an increase in blood glucose levels, which can be initiated or diagnosed during pregnancy. This process occurs due to the production of high levels of hormones by the placenta, most of which are harmful to the action of insulin in the cells increasing the blood sugar level and can affect the growth
Prevalence of anxiety among gestationaldiabetes mellitus patients: A systematic review and meta-analysis Prevalence of anxiety among gestationaldiabetes mellitus patients: A systematic review and meta-analysis BPG is committed to discovery and dissemination of knowledge This Article Full Article (HTML) (37) Full Article (PDF) (16) Academic Content and Language Evaluation of This Article CrossCheck and Google Search of This Article Academic Rules and Norms of This Article Supplementary (...) Materials of This Article Citation of this article Lee KW, Loh HC, Chong SC, Ching SM, Devaraj NK, Tusimin M, Abdul Hamid H, Hoo FK. Prevalence of anxiety among gestationaldiabetes mellitus patients: A systematic review and meta-analysis. World J Meta-Anal 2020; 8(3): 275-284 Corresponding Author of This Article Siew Mooi Ching, MD, MMed (FamMed), Associate Professor, Department of Family Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia
Probiotic treatment for women with gestationaldiabetes to improve maternal and infant health and well-being. Gestationaldiabetes mellitus (GDM) is carbohydrate intolerance first recognised during pregnancy and associated with complications for mothers and babies. Probiotics are naturally occurring micro-organisms, which when ingested in adequate amounts, may confer health benefits. Evidence of the role of probiotics as treatment for GDM is limited.To evaluate the safety and effectiveness (...) possible benefit and possible harm. No trials reported primary outcomes of: mode of birth as vaginal/assisted and subsequent development of type 2 diabetes. We are uncertain if probiotics have any effect compared with placebo on induction of labour (RR 1.33, 95% CI 0.74 to 2.37; participants = 127; studies = 1; very low-certainty evidence). For other secondary maternal outcomes, we are uncertain if there are differences between probiotics and placebo for: postpartum haemorrhage; weight gain during
Interventions to prevent women from developing gestationaldiabetes mellitus: an overview of Cochrane Reviews. The prevalence of gestationaldiabetes mellitus (GDM) is increasing, with approximately 15% of pregnant women affected worldwide, varying by country, ethnicity and diagnostic thresholds. There are associated short- and long-term health risks for women and their babies.We aimed to summarise the evidence from Cochrane systematic reviews on the effects of interventions for preventing (...) GDM.We searched the Cochrane Database of Systematic Reviews (6 August 2019) with key words 'gestationaldiabetes' OR 'GDM' to identify reviews pre-specifying GDM as an outcome. We included reviews of interventions in women who were pregnant or planning a pregnancy, irrespective of their GDM risk status. Two overview authors independently assessed eligibility, extracted data and assessed quality of evidence using ROBIS and GRADE tools. We assigned interventions to categories with graphic icons
A systematic review and meta-analysis protocol to compare the risk of attrition among prenatal vitamin D supplemented gestationaldiabetes mellitus patients with its non-recipients. A systematic review and meta-analysis protocol to compare the risk of attrition among prenatal vitamin D supplemented gestationaldiabetes mellitus patients with its non-recipients | medRxiv Search for this keyword A systematic review and meta-analysis protocol to compare the risk of attrition among prenatal vitamin (...) D supplemented gestationaldiabetes mellitus patients with its non-recipients Sumanta Saha doi: https://doi.org/10.1101/2020.05.22.20110262 Sumanta Saha 1 Affiliaton: None For correspondence: ABSTRACT Aim Recently, several clinical trials have tested the effect of prenatal vitamin D supplementation in gestationaldiabetes mellitus (GDM) patients and their newborns. However, their participant attrition, an important determinant of the internal validity, remains poorly explored. Therefore
Progression to type 2 diabetes in women with a known history of gestationaldiabetes: systematic review and meta-analysis. To estimate and compare progression rates to type 2 diabetes mellitus (T2DM) in women with gestationaldiabetes mellitus (GDM) and healthy controls.Systematic review and meta-analysis.Medline and Embase between January 2000 and December 2019, studies published in English and conducted on humans.Observational studies investigating progression to T2DM. Inclusion criteria were (...) postpartum follow-up for at least 12 months, incident physician based diagnosis of diabetes, T2DM reported as a separate outcome rather than combined with impaired fasting glucose or impaired glucose tolerance, and studies with both a group of patients with GDM and a control group.This meta-analysis of 20 studies assessed a total of 1 332 373 individuals (67 956 women with GDM and 1 264 417 controls). Data were pooled by random effects meta-analysis models, and heterogeneity was assessed by use of the I2
Effects of MTNR1B Genetic Variants on Individual Susceptibility to GestationalDiabetes Mellitus: A Meta-Analysis. Whether melatonin receptor 1B (MTNR1B) variants are implicated in gestationaldiabetes mellitus (GDM) remains unclear. Therefore, we performed this meta-analysis to obtain a more conclusive result on associations between MTNR1B variants and GDM. Literature research was performed in PubMed, Web of Science, Embase, and China National Knowledge Infrastructure. Odds ratios (ORs
Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating GestationalDiabetes Mellitus: A Meta-Analysis. To compare the efficacy and safety of metformin, glyburide, and insulin in treating gestationaldiabetes mellitus (GDM), a meta-analysis of randomized controlled trials (RCTs) was conducted. PubMed, Embase, CINAHL, Web of Science, and Cochrane Library to November 13, 2018, were searched for RCT adjusted estimates of the efficacy and safety of metformin, glyburide (...) to 0.86; P < 0.05). To the outcomes of birth weight and gestational age at delivery, insulin had a significant increase when compared with metformin (MD, 114.48; 95% CI, 37.32 to 191.64; P < 0.01; MD, 0.23; 95% CI, 0.12 to 0.34; P < 0.001; respectively). Of the two groups between glyburide and metformin, metformin had lower gestational weight gain compared with glyburide (MD, 1.67; 95% CI, 0.26 to 3.07; P < 0.05). Glyburide had a higher risk of neonatal hypoglycemia compared with insulin (RR, 1.76; 95
Relationship between Maternal Central Obesity and the Risk of GestationalDiabetes Mellitus: A Systematic Review and Meta-Analysis of Cohort Studies. Nowadays, body mass index (BMI) is used to evaluate the risk stratification of obesity-related pregnancy complications in clinics. However, BMI cannot reflect fat distribution or the proportion of adipose to nonadipose tissue. The objective of this study is to evaluate the association of maternal first or second trimester central obesity
Maternal age and the risk of gestationaldiabetes mellitus: A systematic review and meta-analysis of over 120 million participants. The objective of the present analysis was to evaluate and quantify the risk for gestationaldiabetes mellitus (GDM) according to maternal age.Three electronic databases were searched for publications from inception to July 2018. Odds ratio (OR) and 95% confidence interval (95% CI) were calculated. A dose-response analsis was performed using generalised least
Polyphenol-rich foods and risk of gestationaldiabetes: a systematic review and meta-analysis. Animal studies have demonstrated anti-diabetic properties of several food-derived polyphenols, but data in humans remains unclear. This study aimed to review and meta-analyse evidence concerning the effect of the intake of several polyphenol-rich foods on gestationaldiabetes (GDM) risk. A systematic literature search was conducted in PubMed, Web of Science and Embase databases for observational
Association between intrahepatic cholestasis of pregnancy and risk of gestationaldiabetes and preeclampsia: a systematic review and meta-analysis. Objective: To investigate the association between intrahepatic cholestasis of pregnancy (ICP) and the risk of gestationaldiabetes mellitus (GDM) and preeclampsia via meta-analysis.Methods: Pooled odds ratio (OR) and confidence interval (CI) of GDM and preeclampsia for women with ICP were calculated using the fixed- or random-effects model.Results
Metformin in pregnancy to avert gestationaldiabetes in women at high risk: Meta-analysis of randomized controlled trials. Previous randomized and observational studies on the efficacy of metformin in pregnancy to reduce incident gestationaldiabetes mellitus (GDM) in women at high risk (obesity, polycystic ovary syndrome [PCOS], or pregestational insulin resistance) have been conflicting and several groups are planning further randomized controlled trials (RCTs) to answer this question (...) conclusively. This work assesses the efficacy of metformin in pregnancy to avert one outcome-incident GDM in women at high risk. We included RCTs comparing metformin with usual care or placebo controls in terms of incident GDM and recruiting women at high risk during early pregnancy. Eleven eligible trials enrolled 2370 adult women whose intervention arm consisted of metformin started at conception or before 20 weeks of gestation. Risk of GDM was similar in intervention compared with controls (risk ratio
Burden, risk factors and maternal and offspring outcomes of gestationaldiabetes mellitus (GDM) in sub-Saharan Africa (SSA): a systematic review and meta-analysis. The burden, determinants and outcomes of gestationaldiabetes mellitus (GDM) in sub-Saharan Africa are not known. We summarized existing evidence on the prevalence, risk factors and complications of GDM in the region.PubMed was searched from inception to January 31st 2019. Studies were included if carried out in any of the sub (...) and previous history of GDM, macrosomia, stillbirth and abortion were important risk factors of GDM. In addition, being overweight or obese, over 25 years of age or hypertensive increased the risk of GDM. In terms of complications, GDM more than doubles the risk macrosomia (RR; 95%CI: 2.2; 1.1-4.4).There is a high burden of gestationaldiabetes mellitus in sub-Saharan Africa, but more studies are needed to document locally important risk factors as well as maternal and offspring outcomes. Interventions
Role of C-reactive Protein(CRP) or high-sensitivity CRP in predicting gestationaldiabetes Mellitus:Systematic review. GestationalDiabetes Mellitus (GDM) is the most common disorder during pregnancy in 8-18% of pregnancies. Due to maternal and neonatal morbidity and mortality, early diagnosis and appropriate treatment have always been of interest to researchers. One of the recent cases for early diagnosis of GDM is the size of the C-reactive protein (CRP). The purpose of this review study (...) was to investigate the role of CRP or its high sensitivity type in predicting GDM.Systematic searching of MEDLINE, ISI Web of Science, PubMed, Scopus, Google Scholar, and ProQuest databases between 2009 and 2019 using keywords 'GestationalDiabetes Mellitus','Screening', 'C-reactive protein',' High sensitivity CRP'was performed. The quality of articles was also assessed using the STROBE checklist.After a thorough search of the mentioned databases, 31 articles with the desired quality were finally selected. Most